Cargando…

Identification of metabolism-associated genes and pathways involved in different stages of clear cell renal cell carcinoma

The lack of early diagnostic markers and novel therapeutic targets for clear cell renal cell carcinoma (ccRCC) negatively affects patient prognosis. Cancer metabolism is an attractive area for the understanding of the molecular mechanism of carcinogenesis. The present study attempted to identify met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hui-Juan, Li, Wen-Xing, Dai, Shao-Xing, Guo, Yi-Cheng, Zheng, Jun-Juan, Liu, Jia-Qian, Wang, Qian, Chen, Bi-Wen, Li, Gong-Hua, Huang, Jing-Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776935/ https://www.ncbi.nlm.nih.gov/pubmed/29434939 http://dx.doi.org/10.3892/ol.2017.7567

Ejemplares similares

The identification and molecular mechanism of anti-stroke traditional Chinese medicinal compounds
por: Liu, Jia-Qian, et al.
Publicado: (2017)

In silico identification of anti-cancer compounds and plants from traditional Chinese medicine database
por: Dai, Shao-Xing, et al.
Publicado: (2016)

Corrigendum: In silico identification of anti-cancer compounds and plants from traditional Chinese medicine database
por: Dai, Shao-Xing, et al.
Publicado: (2016)

A strategy to find novel candidate anti-Alzheimer’s disease drugs by constructing interaction networks between drug targets and natural compounds in medical plants
por: Chen, Bi-Wen, et al.
Publicado: (2018)

Identification of HIPK3 as a potential biomarker and an inhibitor of clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2021)

Homocysteine Metabolism Gene Polymorphisms (MTHFR C677T, MTHFR A1298C, MTR A2756G and MTRR A66G) Jointly Elevate the Risk of Folate Deficiency
por: Li, Wen-Xing, et al.
Publicado: (2015)

Low expression of aging-related NRXN3 is associated with Alzheimer disease: A systematic review and meta-analysis
por: Zheng, Jun-Juan, et al.
Publicado: (2018)

Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis
por: Chen, Liang, et al.
Publicado: (2018)

Prediction of pathological staging and grading of renal clear cell carcinoma based on deep learning algorithms
por: Wen-zhi, Gao, et al.
Publicado: (2022)

Application of DKI and IVIM imaging in evaluating histologic grades and clinical stages of clear cell renal cell carcinoma
por: Cheng, QiChao, et al.
Publicado: (2023)

Identification of key genes involved in the metastasis of clear cell renal cell carcinoma
por: Wei, Wenhao, et al.
Publicado: (2019)

Identification of Core Genes Involved in the Metastasis of Clear Cell Renal Cell Carcinoma
por: Peng, Rui, et al.
Publicado: (2020)

IGLL5 is correlated with tumor‐infiltrating immune cells in clear cell renal cell carcinoma
por: Xia, Zhi‐Nan, et al.
Publicado: (2021)

Identification of genes and pathways involved in kidney renal clear cell carcinoma
por: Yang, William, et al.
Publicado: (2014)

Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma
por: Xia, Zhi-Nan, et al.
Publicado: (2022)

Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
por: Wei, Yuang, et al.
Publicado: (2021)

Identification of an immune-related risk signature for predicting prognosis in clear cell renal cell carcinoma
por: Hua, Xiaoliang, et al.
Publicado: (2020)

Overexpression of BMP1 reflects poor prognosis in clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2019)

IQGAP3 in clear cell renal cell carcinoma contributes to drug resistance and genome stability
por: Li, Wen, et al.
Publicado: (2022)

AB188. Vasohibin-1 and microvessel density predict prognosis in clear cell renal cell carcinoma
por: Tian, Hao, et al.
Publicado: (2016)

Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma
por: Dong, Yang, et al.
Publicado: (2021)

Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy
por: Zhang, Cuijian, et al.
Publicado: (2022)

Integrated analysis of ischemic stroke datasets revealed sex and age difference in anti-stroke targets
por: Li, Wen-Xing, et al.
Publicado: (2016)

Author Correction: Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma
por: Xia, Zhi-Nan, et al.
Publicado: (2023)

High Expression of GSDMC Is Associated with Poor Survival in Kidney Clear Cell Cancer
por: Cui, Yun-Qian, et al.
Publicado: (2021)

Metabolic Syndrome is an Independent Risk Factor for Fuhrman Grade and TNM Stage of Renal Clear Cell Carcinoma
por: Zhang, Qian, et al.
Publicado: (2022)

CDCA2 acts as an oncogene and induces proliferation of clear cell renal cell carcinoma cells
por: Li, Fang, et al.
Publicado: (2020)

Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Chen, Mei, et al.
Publicado: (2020)

Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients
por: Li, Zhengtian, et al.
Publicado: (2021)

Identification of METTL14 in Kidney Renal Clear Cell Carcinoma Using Bioinformatics Analysis
por: Wang, Qian, et al.
Publicado: (2019)

Identification of KIF20A as a tumor biomarker and forwarder of clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2021)

Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma
por: Wang, Jiyan, et al.
Publicado: (2022)

Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis
por: Zhou, Lu, et al.
Publicado: (2022)

Comprehensive bioinformatics analyses of APOBECs family and identification of APOBEC3D as the unfavorable prognostic biomarker in clear cell renal cell carcinoma
por: Zhu, Zhenpeng, et al.
Publicado: (2021)

Identification of Potential Serum Proteomic Biomarkers for Clear Cell Renal Cell Carcinoma
por: Yang, Juan, et al.
Publicado: (2014)

Prognostic and immunological significance of calcium-related gene signatures in renal clear cell carcinoma
por: Liu, An, et al.
Publicado: (2022)

Identification of Hypoxia–Immune-Related Gene Signatures and Construction of a Prognostic Model in Kidney Renal Clear Cell Carcinoma
por: Bai, Shuheng, et al.
Publicado: (2022)

Identification of IRF-associated molecular subtypes in clear cell renal cell carcinoma to characterize immunological characteristics and guide therapy
por: Chen, Can, et al.
Publicado: (2023)

Gain and loss events in the evolution of the apolipoprotein family in vertebrata
por: Liu, Jia-Qian, et al.
Publicado: (2019)

Identification of hub genes associated with outcome of clear cell renal cell carcinoma
por: Li, Rengui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2tnfh1thnsk6j80agts5176lbc